For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Allergan, Inc.

USPTO Granted Patents = 2,285

CIPO Patents = 717

EPO Patents = 526

Trademarks = 210

Forward Citations = 49,971

Loading Chart...

Loading Chart...

1,210 inventors (with patents filed for the assignee):

Michael E Garst (188 out of 212 patents)

Roshantha A Chandraratna (156 out of 291 patents)

John E Donello (134 out of 136 patents)

4. Robert M Burk (134 out of 166 patents)

5. Ken Chow (120 out of 124 patents)

6. Kei Roger Aoki (116 out of 126 patents)

7. Richard L Beard (116 out of 138 patents)

8. David W Old (111 out of 115 patents)

9. Lance Steward (101 out of 102 patents)

10. David Frederick Woodward (98 out of 113 patents)

11. Patrick Michael Hughes (83 out of 90 patents)

12. Daniel W Gil (75 out of 84 patents)

13. Ester Fernandez-Salas (72 out of 76 patents)

14. Larry Allen Wheeler (68 out of 76 patents)

15. James Nienyuan Chang (64 out of 68 patents)

Core Competencies:

Botulinum Toxin

Dermal Fillers

Tissue Expansion

Clostridial Toxin

Hyaluronic Acid

Injection Devices

Pharmaceutical Compositions

Retinal Diseases

Presbyopia Treatments

Microneedle Arrays

Antimicrobial Efficacy

Fusion Proteins

2,285 patents: Sort by Forward Citations

1. 12409211 - Non-protein Clostridial toxin compositions (2025-09-09),

2. 12241098 - Process and system for obtaining botulinum neurotoxin (2025-03-04),

3. 12208155 - Method for improving duration of effect of dermal filler treatment (2025-01-28),

4. 12171816 - Non-protein Clostridial toxin compositions (2024-12-24),

5. 12144847 - Non-protein clostridial toxin compositions (2024-11-19),

6. 12004995 - Intraocular implant with high loading of a prostamide (2024-06-11),

7. 11992668 - Injection device (2024-05-28),

8. D1027647 - Bottle holder (2024-05-21),

9. 11944533 - Implantable prostheses for tissue expansion (2024-04-02),

10. 11890457 - Aspiration and injection device (2024-02-06),

11. 11844878 - Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation (2023-12-19),

12. 11833269 - Hyaluronic acid-collagen matrices for dermal filling and volumizing applications (2023-12-05),

13. 11819541 - Injection paradigm for administration of botulinum toxins (2023-11-21),

14. 11738043 - Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced toxicity (2023-08-29),

15. 11684719 - Methods of treatment using a syringe extrusion accessory (2023-06-27),

Allergan, Inc. is a global pharmaceutical company that specializes in the development, manufacturing, and commercialization of prescription medicines, medical aesthetics, and over-the-counter consumer healthcare products. With a focus on innovation, Allergan aims to enhance the health and well-being of people worldwide. They offer a diverse portfolio of products that address various therapeutic areas, including eye care, central nervous system, gastroenterology, and more. Allergan operates in over 100 countries and is committed to delivering high-quality healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

2,285 Patents

#3 in Irvine, CA

#54 in California

#213 in US

#429 in the World

Irvine, CA, United States of America

Allergan, Inc.

Forward Citations = 49,971

1,210 inventors:

Michael E Garst (188 out of 212 patents)

Roshantha A Chandraratna (156 out of 291 patents)

John E Donello (134 out of 136 patents)

4. Robert M Burk (134 out of 166 patents)

5. Ken Chow (120 out of 124 patents)

Please report any incorrect information to support@idiyas.com

Loading…